Department of Pharmaceutical Chemistry

Promising new drug flags evasive cancer cells for destruction

UCSF researchers use combination therapy to expose cancerous protein targets to the immune system 

A chemical biology approach to studying innate immunity, a QBI/SBI Online Seminar with Balyn Zaro

The QBI/SBI Seminar Series on molecular networks of cancer and other diseases aims to facilitate collaborative relationships between scientists from both the US and Ireland.

Nobel Laureate Jennifer Doudna on Gene Editing and the Future of CRISPR

QBI presents a Twitter Space (live audio conversation) with Jennifer Doudna, Nobel Laureate, co-inventor of CRISPR-Cas9, professor of cellular molecular pharmacology at UCSF, and biochemist at the University of California, Berkeley. Doudna received her PhD in biological chemistry and molecular...

Meme Machine: a QBI Hybrid Seminar with John Walter

The QBI seminar series is presenting John Walter, a visual artist based in London with a longstanding interest in HIV, infectious diseases, and a commitment to expanding the public understanding of virology through projects such as Alien Sex Club (2015) and CAPSID (2018). He works across a diverse...

Arezou Razavi

CCB Program Manager





I manage the Chemistry and Chemical Biology Graduate Program. As graduate program coordinator, I manage all aspects of the program including admissions and recruitment, funding, grants, events, and curriculum.



The Way Forward: Recognizing Women’s Contributions to Science

The Quantitative Biosciences Institute (QBI) at UCSF is presenting a live QBI TV panel discussion titled, “The Way Forward: Recognizing Women’s Contributions to Science,” to highlight the need to increase the inclusion and acknowledgment of women in science. 

Identifying novel therapeutic targets in high-risk MYCN-amplified neuroblastoma: a QBI/SBI Online Seminar with Melinda Halasz

The QBI/SBI Seminar Series on molecular networks of cancer and other diseases aims to facilitate collaborative relationships between scientists from both the US and Ireland. QBI and UCD recently signed a 5-year MOU to reinforce the links between scientists in San Francisco and Dublin, and enhance...

Behind enemy lines

School scientists make headway against antibiotic-resistant bacteria

Pirating proteins for biomedicine

Wells reflects on his trailblazing career in protein engineering

Pages